Human opsonins to meningococci after vaccination

22Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Two groups of volunteers were immunized with either a serogroup A plus C meningococcal polysaccharide vaccine or a combined serogroup B polysaccharide-serotype 2 protein vaccine. Serum opsonin responses were measured by chemiluminescence of polymorphonuclear leukocytes exposed to opsonized live meningococci . Two of the 6 volunteers immunized with the A plus C vaccine had an increase in serum opsonins to group A meningococci, 4 responded to group C meningococci, and none to group B meningococci. Five other volunteers who were immunized with the combined group B polysaccharide-serotype 2 protein vaccine responded with an increase in serum opsonins to group B meningococci of two different protein serotypes, as well as to a group C-serotype 2 meningococcal strain. Although no booster effect was observed after a second dose of the combined vaccine, both the polysaccharide and the protein components appear to be able to stimulate an opsonin response.

Cite

CITATION STYLE

APA

Halstensen, A., Haneberg, B., Oddvar Frøholm, L., Lehmann, V., Frasch, C. E., & Solberg, C. O. (1984). Human opsonins to meningococci after vaccination. Infection and Immunity, 46(3), 673–676. https://doi.org/10.1128/iai.46.3.673-676.1984

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free